Showing results (201-210 of 2,480) with videos related to

Sort By:
Pageof 248
Pediatric Hematology and Oncology|March 27, 2009
Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiencyBetul Tavil, Ozden Sanal, Tuba Turul, et al.
Pediatric Hematology and Oncology|January 1, 1986
The effect of abdominal radiation on spleen function: a study in children with Wilms' tumorM Stevens, E Brown, A Zipursky
Pediatric Hematology and Oncology|December 6, 2005
Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphomaF Visal Okur, Aynur Oguz, Ceyda Karadeniz, et al.
Pediatric Hematology and Oncology|December 6, 2005
Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporineJian-Pei Fang, Hong-Gui Xu, Shao-Liang Huang, et al.
Pediatric Hematology and Oncology|December 6, 2005
Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndromeMohammad Amin Kashef, Sara Kashef, Farhad Handjani, et al.
Pediatric Hematology and Oncology|March 6, 2010
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapyEllen Butensky James, Hendrik J Vreman, Ronald J Wong, et al.
Pediatric Hematology and Oncology|March 6, 2010
Successful mobilization with AMD3100 and filgrastim with engraftment of autologous peripheral blood stem cells in a heavily pretreated pediatric patient with recurrent Burkitt lymphomaTerrie Flatt, Karen Lewing, Celia Gonzalez, et al.
Pediatric Hematology and Oncology|March 6, 2010
Isolated central nervous system involvement by lymphomatoid granulomatosis in an adolescent: a case report and review of literatureTejpal Gupta, Tabassum Wadasadawala, Tanuja Shet, et al.
Pediatric Hematology and Oncology|April 13, 2018
Inflammatory cytokines and depression in children with cancer: A review of the literatureGaya Narendran, Lianne Tomfohr, Fiona Schulte
Pediatric Hematology and Oncology|May 1, 1994
6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemiaS P Dibenedetto, V Guardabasso, R Ragusa, et al.
Pageof 248